Emerging evidence for adapting radiotherapy to immunotherapy

Area of Science:

• Oncology
• Immunology
• Radiation Oncology

Background:

• Immunotherapy has transformed cancer care but often lacks durable responses as a single agent.
• Radiotherapy is a common cancer treatment with potential immunostimulatory effects, making it a candidate for combination therapy.
• Clinical trials combining radiotherapy and immunotherapy have yielded disappointing results, suggesting issues with current strategies.

Purpose of the Study:

• To propose that modifying standard radiotherapy regimens and target volumes is crucial for successful immunotherapy combinations.
• To enhance anti-tumor immune responses and achieve meaningful clinical benefits by optimizing radiotherapy's immunostimulatory potential.

Main Methods:

• This study is conceptual, proposing a new framework for radiotherapy-immunotherapy combinations.
• It reviews existing literature on radiotherapy, immunotherapy, and their combination trials.
• It emphasizes the need to consider immune effects in radiotherapy planning.

Main Results:

• Current radiotherapy schedules and target volumes are optimized for direct tumor killing, not immune stimulation.
• A lack of synergy in previous trials may stem from suboptimal radiotherapy administration.
• Modifying radiotherapy parameters could enhance immune fitness and anti-tumor responses.

Conclusions:

• Successful radiotherapy-immunotherapy combinations require tailored radiotherapy approaches.
• Optimizing radiotherapy to support the immune system is key to improving cancer treatment efficacy.
• Future research should focus on novel radiotherapy strategies to maximize combination benefits.